about
The E3-ubiquitin ligase TRIM50 interacts with HDAC6 and p62, and promotes the sequestration and clearance of ubiquitinated proteins into the aggresomeThe burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern ItalyEffects of hypercapnia on peripheral vascular reactivity in elderly patients with acute exacerbation of chronic obstructive pulmonary diseaseIdiopathic deep venous thrombosis and arterial endothelial dysfunction in the elderly.Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data.Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients.Comparing the prognostic accuracy for all-cause mortality of frailty instruments: a multicentre 1-year follow-up in hospitalized older patientsModeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients.Italian multicenter experience with flow-diverter devices for intracranial unruptured aneurysm treatment with periprocedural complications--a retrospective data analysis.FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer's disease.Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis.Joint effect of insulin signaling genes on all-cause mortality.Association between resistin levels and all-cause and cardiovascular mortality: a new study and a systematic review and meta-analysisAssociation of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study.Target values of cardiovascular risk factors are not associated with all-cause mortality in patients with type 2 diabetes mellitusTRIM8 downregulation in glioma affects cell proliferation and it is associated with patients survivalComparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based StudyHow Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009-2013.Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational studyCompetitive allele-specific TaqMan PCR (Cast-PCR) is a sensitive, specific and fast method for BRAF V600 mutation detection in Melanoma patients.Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetesTime related variations in stem cell harvesting of umbilical cord blood.Development of an oncological-multidimensional prognostic index (Onco-MPI) for mortality prediction in older cancer patients.Infrequent TRIB3 coding variants and coronary artery disease in type 2 diabetes.Change in the Multidimensional Prognostic Index Score During Hospitalization in Older Patients.Development and validation of a predicting model of all-cause mortality in patients with type 2 diabetes.Addition of the multidimensional prognostic index to the estimated glomerular filtration rate improves prediction of long-term all-cause mortality in older patients with chronic kidney disease.Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma.Stepwise analysis of MIR9 loci identifies miR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patients.Advances in meta-analysis: examples from internal medicine to neurology.Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting.Functional outcome of critical illness polyneuropathy in patients affected by severe brain injury.Modeling and Prediction in Neurological Disorders: The Biostatistical Perspective.SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: Effect of starvation.Examination of level of knowledge in Italian general practitioners attending an education session on diagnosis and management of the early stage of Alzheimer's disease: pass or fail?Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009-2015.Stratification of ALS patients' survival: a population-based study.Population-Based Evidence that Survival in Amyotrophic Lateral Sclerosis is Related to Weight Loss at Diagnosis.Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival.The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based Study.
P50
Q24293114-86864F0D-0957-4F14-8B0F-7C95FE1A7E3AQ28539876-1AB4EE9A-B95A-482D-BEBD-5A0099A92B8CQ30437135-8FCC3FBF-BA65-4CD9-958C-9379D5A7CD68Q30453932-754075A1-8BAC-4FB1-9392-C4B3FB928083Q31168181-AAD00D01-7940-47E8-88FF-4B65E9A47D38Q33747550-8CCDA337-6A70-4F1C-ACF2-226D7C165E1CQ34128438-7C18DC7B-98E3-440E-A126-3E3C55D001ACQ34234101-F158AA9A-A451-42C4-8743-5C818B934DE3Q34262764-DE05537D-4A0C-41B7-BAAE-79791C6CCD35Q34415342-B0D7A3CC-3027-4E36-A4CF-1B985E02300BQ34508879-6D38A606-40F3-40FF-99F4-5642DD942D1CQ34954938-D1BBBB66-2DD4-46D3-91D9-CCF367941DE3Q35201927-2123200B-BD89-4DCD-B9AB-8C33CF162265Q35448046-9EB0C24D-0FEF-4662-A350-C4F864B66749Q35558180-01FB700E-0034-43D7-AAC3-4EC405C1ACEDQ35664663-A476913F-6307-494D-94AB-0C43F6E209D8Q36019803-6D73FFF5-0E50-4DD6-952D-10490904D9FCQ36034344-BF1E37A8-C894-4DA8-9401-B092833A8E59Q36039036-7FFD22F1-701A-45FE-AF17-827D4D6AAA4CQ36392912-8E84835E-FD56-4068-A35C-A9B93224A55AQ36513591-3D392152-A5F6-41CA-80A3-0991542C07E6Q36611123-196C13BC-E2BA-44B8-9884-D7722B29C887Q36789292-5F29BB8D-87AC-49A2-8C5E-3A523A3BA90FQ36915682-3E3B079C-99A5-48F3-9B3B-31CB90B76A00Q37061268-9C490BB3-2319-4F4A-8B19-E5B4181DE965Q37106533-3FB3E7AE-F84D-4FC4-943B-DF53E1E23063Q37656111-326A0BF8-4C16-402C-994B-D684DE859C5AQ37706890-95A2BD54-E748-4330-A309-BBC1A80E13EAQ37721631-7F04650F-950E-4C78-AC4F-A808B7903D46Q38172773-BFC9A84E-02F2-4C91-BEF1-18BEEF36F257Q38670983-D4634A03-5444-4F9C-AA9C-E9A87F8861B8Q38833173-8EAA2F77-F6A6-4011-8708-FD390B809962Q38837388-2E213D54-B162-4D0E-9FEC-2636D2622F78Q38896426-EA8863FC-2E74-4B34-8C92-AA2AE881C42CQ38915520-6F655C6C-5F12-40A0-8154-3337C465A68DQ38982621-61159D93-FE40-43DA-8CE5-75FDD9BB1523Q39215197-DFA44EE3-4942-4998-9AAE-1602B3282AF3Q39215220-3292A794-F78B-448F-A8CE-2D18D19AE04DQ39286125-33A58507-4259-489B-BFE1-40237FFBCFA0Q39595929-EC41B1C2-2193-4239-9340-05911C2F5EE7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andrea Fontana
@ast
Andrea Fontana
@en
Andrea Fontana
@es
Andrea Fontana
@nl
type
label
Andrea Fontana
@ast
Andrea Fontana
@en
Andrea Fontana
@es
Andrea Fontana
@nl
prefLabel
Andrea Fontana
@ast
Andrea Fontana
@en
Andrea Fontana
@es
Andrea Fontana
@nl
P1053
J-8584-2016
P106
P1153
35573405800
P31
P3829
P496
0000-0002-6660-5315